(Q73595223)

English

Serum predominantly activates MAPK and akt kinases in EGFR- and ErbB2-over-expressing cells, respectively

scientific article published on 01 April 2000

Statements

Serum predominantly activates MAPK and akt kinases in EGFR- and ErbB2-over-expressing cells, respectively (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit